Monoclonal antibody therapy of leukaemias and lymphomas.

about

Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia Monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia Poor outcomes in elderly kidney transplant recipients receiving alemtuzumab induction.

P2860

Q24203027-0405A2D5-9E4B-4669-BFA0-B376AFA4A1AB Q24241519-A1BBE011-915F-4CEB-83BD-E765215120C5 Q35611179-9A57D29D-3FAD-4D03-98E8-E337DAE3AA76

P2860

Monoclonal antibody therapy of leukaemias and lymphomas.

Item

http://www.wikidata.org/entity/Q36239669

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Monoclonal antibody therapy of leukaemias and lymphomas.

@ast

Monoclonal antibody therapy of leukaemias and lymphomas.

@en

type

Item

label

Monoclonal antibody therapy of leukaemias and lymphomas.

@ast

Monoclonal antibody therapy of leukaemias and lymphomas.

@en

prefLabel

Monoclonal antibody therapy of leukaemias and lymphomas.

@ast

Monoclonal antibody therapy of leukaemias and lymphomas.

@en

P1476

Monoclonal antibody therapy of leukaemias and lymphomas.

@en

P2093

Kenneth A Foon

http://www.w3.org/2001/XMLSchema#string

Samuel A Jacobs

http://www.w3.org/2001/XMLSchema#string

P2860

Continuous cultures of fused cells secreting antibody of predefined specificity

Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions.

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia

Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type

Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma

New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project

P304

1225-1243

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.5.9.1225

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16120052

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

Monoclonal antibody therapy of leukaemias and lymphomas.

about

P2860

P2860

Monoclonal antibody therapy of leukaemias and lymphomas.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921